Gastrointestinal Therapeutics Market - By Drug Class (Aminosalicylates, Antacids, Antidiarrheals, Antiemetics, Antiulcer Agents, Biologics, Laxatives, Proton Pump Inhibitors (PPIs), H2 Receptor Antagonists, Prokinetics, Antibiotics), By Indication (Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease, Irritable Bowel Syndrome (IBS), Inflammatory Disease (IBD), Diarrhea, Constipation, Nausea and Vomiting, Celiac Disease, Others), By End User (Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers), and By Country (Japan, China, India, South Korea, Australia & NZ, ASEAN, Rest of Asia-Pacific)

$2400.00